SCHEMBL6235747

SCHEMBL6235747

CC(C)(C)OC(=O)NCC(=O)N1CCN(c2cnc3nc(-c4cccs4)c(-c4cccs4)nc3c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.43
SIGMAR1 Q99720 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
RAB9A P51151 1/20 0.40
FNTA P49354 2/20 0.40
FNTB P49356 2/20 0.40
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
PKM P14618 1/20 0.38
MAPT P10636 4/20 0.38
HDAC3 O15379 1/20 0.38
LMNA P02545 1/20 0.38
THRB P10828 2/20 0.37
GFER P55789 1/20 0.37
MAPK8 P45983 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
MET P08581 2/20 0.37
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6235513 0.86 GBA1 (0.55) GBA1SMN1; SMN2MAPTLMNACKS1B
SCHEMBL6260215 0.85 GBA1 (0.43) GBA1SMN1; SMN2KDM4EHSD17B10MAPT
SCHEMBL6235323 0.83 GBA1 (0.40) GBA1SMN1; SMN2FNTAFNTBKDM4E
SCHEMBL6236245 0.81 ALDH1A1 (0.45) SMN1; SMN2KDM4EHSD17B10MAPTHDAC3
SCHEMBL6235489 0.80 GBA1 (0.50) GBA1SMN1; SMN2KDM4EHSD17B10MAPT
SCHEMBL6241275 0.72 GBA1 (0.50) GBA1RAB9AKDM4EHSD17B10MAPT
SCHEMBL6231947 0.71 MEN1 (0.51) SMN1; SMN2KDM4EHSD17B10LMNAMET
SCHEMBL6237662 0.70 L3MBTL1 (0.43) GBA1KDM4EHSD17B10PKMMET
SCHEMBL12206782 0.69 GAA (0.58) SIGMAR1SMN1; SMN2KDM4EMAPTLMNA
SCHEMBL6905218 0.69 KMT2A (0.60) SIGMAR1SMN1; SMN2FNTAFNTBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed